Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Olfactory receptor family 4 subfamily F member 29 (OR4F29) is a protein-coding gene that encodes a member of the olfactory receptor family, which interact with odorant molecules in the nasal epithelium to initiate a neuronal response leading to the perception of smell. OR4F29 belongs to the largest gene family in the human genome and is a representative of G protein-coupled receptors (GPCRs), characterized by a seven-transmembrane domain structure shared with many neurotransmitter and hormone receptors. These receptors detect and transduce odorant signals via G protein-mediated pathways. The primary biological function of OR4F29 is odorant recognition and participation in the olfactory signaling pathway. While GPCRs are major drug targets generally, there are currently no approved drugs or established therapeutic interventions targeting this specific receptor. OR4F29 has associations with some rare development disorders via gene copy number variations but is not directly implicated or targeted in common diseases or therapy
Not applicable (no established drugs known to act via this receptor in a therapeutic context)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Olfactory receptor family 4 subfamily F member 29 (OR4F29).